Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$3.3 - $7.28 $89,786 - $198,074
-27,208 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.6 - $10.21 $125,156 - $277,793
27,208 New
27,208 $139,000
Q3 2021

Nov 15, 2021

SELL
$6.59 - $38.71 $6.53 Million - $38.4 Million
-991,521 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$32.1 - $57.78 $751,557 - $1.35 Million
23,413 Added 2.42%
991,521 $39.6 Million
Q1 2021

May 17, 2021

BUY
$42.5 - $75.37 $4.71 Million - $8.36 Million
110,890 Added 12.94%
968,108 $48.4 Million
Q4 2020

Feb 12, 2021

BUY
$33.49 - $57.94 $28.7 Million - $49.7 Million
857,218 New
857,218 $38.4 Million

Others Institutions Holding EAR

About Eargo, Inc.


  • Ticker EAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 39,411,000
  • Market Cap $2.78B
  • Description
  • Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...
More about EAR
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.